A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies

NCT01470209 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumors
Lung Cancer

Interventions

DRUG: BKM120
DRUG: Everolimus

Sponsor

Emory University

Collaborators

[object Object]